Dysfunction of NFE2L1 and other family members causes damage in dopaminergic neuron function through dysregulated transcriptional networks - an attempt to search for candidate drugs for Parkinson's disease using in vitro and in vivo approaches

2022/45/N/NZ5/02443

Keywords

Descriptors

  • NZ5_001: Etiologia chorób człowieka
  • NZ5_003: Patogeneza chorób człowieka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Instytut Genetyki i Hodowli Zwierząt PAN

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Kamila Łuczyńska

Number of co-investigators in the project: 2

Call

PRELUDIUM 21 – announced on 2022-03-28

Amount awarded
209 995 PLN
Project start date
2023-02-02
Project end date
2027-02-01
Project duration
48 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases

    Authors:
    Kamila Łuczyńska, Zhengwen Zhang, Tadeusz Pietras, Yiguo Zhang, Hiroaki Taniguchi
    Academic press:
    Redox Biology (year: 2023, volume: 69, pages: 103003), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.redox.2023.103003 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski